# Hochuen Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hochuen-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.hochuen-medical.com
- Total disclosed funding: $6.2M
- Latest round: Series B (Feb 7, 2023)
- Investors on record: 2

## About

Based in Shenzhen, China, and established in 2016, Hochuen Medical Technology Co., Ltd is a healthcare company that focuses on in vitro diagnosis and instant diagnosis products. The company has 4 manufacturing and R&D bases in Shenzhen, Dongguan, and Malaysia, with approximately tens of thousands of square meters of factories including clean rooms and GMP workshops of different grades, and sales centers in the United States and Singapore. It received healthcare systems certification ISO13485, Customs Advanced Certification AEO, and FDA. The co-founder and CEO Dr. Hui Liu has more than 20 years of experience in the U.S. IVD and microfluidic industries and has worked for several companies including Motorola, CombiMatrix, Genmark, and Beckman Coulter/Danaher. Co-founder, Chairman, and CEO Lijiang Zeng has nearly 20 years of experience in OEM production and management of electronic products for Apple, Google, Samsung, and other companies.

The company mainly provides contract development and manufacturing organization (CDMO) manufacturing services for microfluid chips and biomedical consumables. Its products include micro-fluid bio-chip, in vitro diagnosis (IVD) disposable consumables, real-time diagnosis (POCT) test boxes, life science research testing consumables, gene sequencing chips, animal and plant disease testing cards, food safety testing chips, etc.

## Funding rounds

- Series B, Feb 7, 2023 — Qiming Venture Partners, CoStone Capital
- Series A, Jul 12, 2021, $6.2M — Qiming Venture Partners

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B